bioRxivMicrobiologyPreprint
Dissecting pOXA-48 fitness effects in clinical enterobacteria using plasmid-wide CRISPRi screens
Alicia Calvo‐VillamañániD, Jorge Sastre-DomíngueziD, Álvaro Barrera-MartíniD, Coloma CostasiD, Álvaro San MillániD
Abstract
Conjugative plasmids are the main vehicle for the spread of antimicrobial resistance (AMR) genes in clinical bacteria. AMR plasmids allow bacteria to survive antibiotic treatments, but they also produce physiological alterations in their hosts that commonly translate into fitness costs. Despite the key role of plasmid-associated fitness effects in AMR evolution, their origin and molecular bases remain poorly understood. In this study, we introduce plasmid-wide CRISPR interference (CRISPRi) screens as a tool to dissect plasmid-associated fitness effects. We designed and performed CRISPRi screens targeting the globally distributed carbapenem resistance plasmid pOXA-48 in 13 different multidrug resistant clinical enterobacteria. Our results revealed that pOXA-48 gene-level effects are conserved across clinical strains, and exposed the key role of the carbapenemase-encoding gene, blaOXA-48, as the main responsible for pOXA-48 fitness costs. Moreover, our results highlighted the relevance of postsegregational killing systems in pOXA-48 vertical transmission, and uncovered new genes implicated in pOXA-48 stability. This study sheds new light on the biology and evolution of carbapenem resistant enterobacteria and endorses CRISPRi screens as a powerful method for studying plasmid-mediated AMR.
- organism: human
- research focus: drug response / drug discovery
- research focus: host-pathogen & immune response
- research focus: cell type annotation
- research focus: clustering
- approach: genetic perturbation / CRISPR
- Citations
- 6
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The distribution of fitness effects of plasmid pOXA-48 in clinical enterobacteria
A. Fernandez-Calvet, L. Toribio-Celestino, … J. DelaFuente·bioRxiv·Jul 11, 2023
- Plasmid-chromosome transcriptional crosstalk in multidrug resistant clinical enterobacteria
Laura Toribio-Celestino, Alicia Calvo‐Villamañán, … Álvaro San Millán·Nature CommunicationsPeer-reviewed·Dec 30, 2024
- Within-patient evolution of plasmid-mediated antimicrobial resistance
J. DelaFuente, L. Toribio-Celestino, … A. San Millan·bioRxiv·May 31, 2022
- Antimicrobial resistance level and conjugation permissiveness shape plasmid distribution in clinical enterobacteria
A. Alonso-del Valle, L. Toribio-Celestino, … A. San Millan·bioRxiv·Apr 3, 2023
- Bioinformatic analyses of plasmid resistome changes in pOXA-48
S. M. E. Fordham, A. Mantzouratou, E. Sheridan·bioRxiv·Mar 2, 2022
- Chromosomal resistance mutations facilitate acquisition of multidrug-resistance plasmids in Escherichia coli
Khadija-Siddiqa N. Hanga, Michael A. Brockhurst, Michael J. Bottery·bioRxiv·Apr 15, 2025